Tag: report

Highlights emissions reductions and progress in delivering long-term value

PARIS and CAMBRIDGE, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced its inclusion in the Euronext Tech Leaders segment and Euronext Tech Leaders Index, a Euronext flagship initiative dedicated to increasing the visibility and attractiveness of Europe’s leading and high-growth technology companies among international investors.

Please see below information about transactions made under the second tranche of the 2026 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO).

JACKSONVILLE, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- Proficient Auto Logistics, Inc. (Nasdaq: PAL) (the “Company”) today announced that Rick O’Dell, Chairman and Chief Executive Officer, and Brad Wright, Chief Financial Officer will attend the William Blair Growth Stock Conference on June 2, 2026. During this conference, Messrs. O’Dell and Wright expect to participate in a series of meetings with members of the investment community. The materials used during the meetings will be posted to the Company’s website that day at proficientautologistics.com under “Investor Relations”.

WINTER PARK, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”), an owner and operator of high-quality open-air retail centers located primarily in high-growth markets across the Southeast and Southwest, announced today the sale of Madison Yards, a 163,000-square-foot grocery-anchored shopping center in Atlanta, Georgia (the “Property”) for $73.3 million, representing a price of $451 per square foot.

Targeted to Begin Generating Revenue Between Late 2028 and Mid-2029 Following Siemens Restoration at U.S. Facilities.

POWER1 Study in highly refractory patients with focal onset seizures did not meet its primary success measure